Coagulation activation-induced fibrinolysis biomarker changes depend on thrombophilic risk factors and their clinical phenotype: an interventional in vivo study
S. Reda, N. Schwarz, J. Müller, H. L. McRae, J. Oldenburg, B. Pötzsch, H. Rühl
This study examines how fibrinolysis biomarkers change after rFVIIa-induced coagulation activation in patients with thrombophilia, showing prolonged alterations compared to anticoagulant responses.
bioRxiv · Nov 26, 2023 · PreprintPathology